Wall Street Analysts Predict a 231.05% Upside in Trevi Therapeutics (TRVI): Here's What You Should Know
ZACKS· 2025-07-11 22:56
Trevi Therapeutics, Inc. (TRVI) closed the last trading session at $6.41, gaining 3.9% over the past four weeks, but there could be plenty of upside left in the stock if short-term price targets set by Wall Street analysts are any guide. The mean price target of $21.22 indicates a 231.1% upside potential.The average comprises nine short-term price targets ranging from a low of $13.00 to a high of $29.00, with a standard deviation of $4.92. While the lowest estimate indicates an increase of 102.8% from the c ...
JBT Marel (JBTM) Just Flashed Golden Cross Signal: Do You Buy?
ZACKS· 2025-07-11 22:56
From a technical perspective, JBT Marel Corporation (JBTM) is looking like an interesting pick, as it just reached a key level of support. JBTM's 50-day simple moving average crossed above its 200-day simple moving average, which is known as a "golden cross" in the trading world.There's a reason traders love a golden cross -- it's a technical chart pattern that can indicate a bullish breakout is on the horizon. This kind of crossover is formed when a stock's short-term moving average breaks above a longer-t ...
After Golden Cross, GMS (GMS)'s Technical Outlook is Bright
ZACKS· 2025-07-11 22:56
After reaching an important support level, GMS Inc. (GMS) could be a good stock pick from a technical perspective. GMS recently experienced a "golden cross" event, which saw its 50-day simple moving average breaking out above its 200-day simple moving average.A golden cross is a technical chart pattern that can signify a potential bullish breakout. It's formed from a crossover involving a security's short-term moving average breaking above a longer-term moving average, with the most common moving averages b ...
Here's Why Ontrak (OTRK) Could be Great Choice for a Bottom Fisher
ZACKS· 2025-07-11 22:56
A downtrend has been apparent in Ontrak, Inc. (OTRK) lately. While the stock has lost 12.4% over the past week, it could witness a trend reversal as a hammer chart pattern was formed in its last trading session. This could mean that the bulls have been able to counteract the bears to help the stock find support.The formation of a hammer pattern is considered a technical indication of nearing a bottom with likely subsiding of selling pressure. But this is not the only factor that makes a bullish case for the ...
Novo Nordisk: The Market Doesn't Get It
Seeking Alpha· 2025-07-11 22:55
In my last article , I stated that the fear surrounding Novo Nordisk A/S ( NVO ); ( OTCPK:NONOF ) was overblown. At that time, concerns about competition and the sustainability of NVO's growth in their weight loss segment dimmed investors' confidence. The stock hasn'tGerman Buy-Hold-Check investor. With a master's degree in engineering and management, I am able to understand, quantify, and interpret both the economics and (to some point) the technology of companies.Analyst’s Disclosure:I/we have a beneficia ...
ELV DEADLINE TODAY: ROSEN, LEADING TRIAL ATTORNEYS, Encourages Elevance Health, Inc. Investors with Losses in Excess of $100K to Secure Counsel Before Important July 11 Deadline in Securities Class Action – ELV
GlobeNewswire News Room· 2025-07-11 22:53
NEW YORK, July 11, 2025 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of common stock of Elevance Health, Inc. (NYSE: ELV) between April 18, 2024 and October 16, 2024, both dates inclusive (the “Class Period”), of the important July 11, 2025 lead plaintiff deadline. SO WHAT: If you purchased Elevance common stock during the Class Period you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangemen ...
Brookdale Announces Shareholders Have Elected All Eight of the Company's Directors Based on Preliminary Results
Prnewswire· 2025-07-11 22:52
公司治理与股东会议 - 所有八名董事提名人均获得多数流通股支持当选董事会成员 包括Jordan Asher MD Claudia Drayton Mark Fioravanti Victoria Freed Joshua Hausman Elizabeth Mace Denise Warren和Lee Wielansky [1] - 股东批准了年度会议上提交的所有其他提案 最终结果将由独立选举监察员确认后通过8-K表格提交SEC [3] 战略规划与运营重点 - 公司五大核心战略包括提升运营绩效 优化房地产组合 社区资本再投资 降低杠杆率以及保障居民和员工的高质量环境 [2] - 管理层强调将利用人口结构和行业顺风优势 对2025年已取得的强劲发展势头表示信心 [2] 业务规模与行业地位 - 截至2025年6月30日 公司运营645个老年社区 覆盖41个州 可服务约58,000名居民 [4] - 业务涵盖独立生活 辅助生活 记忆护理和持续护理退休社区 通过医疗保健 酒店服务和房地产领域的专业能力提供定制化解决方案 [4] 企业使命与价值观 - 公司以热情 勇气 合作和信任为四大基石 致力于通过临床专业知识和贴心服务提升老年人生活质量 [4] - 发展目标包括创造健康积极的老年生活模式 促进居民健康管理 个人成长和社交关系建设 [4]
Rise in NII & Fee Income to Aid PNC Financial's Q2 Earnings
ZACKS· 2025-07-11 22:50
公司业绩预期 - PNC Financial Services Group计划于2025年7月16日公布第二季度财报 预计收入和盈利将同比增长 [1] - 第一季度盈利超出Zacks共识预期 主要得益于费用收入、净利息收入(NII)和贷款余额增长 但费用增加和信贷损失拨备对业绩产生负面影响 [1] - 公司过去四个季度盈利均超预期 平均超出幅度达8.39% [2] 净利息收入(NII) - 美联储维持利率在4.25-4.5%区间 有助于稳定PNC的融资/存款成本 支持NII表现 [3] - 贷款需求强劲 商业/工业贷款、房地产贷款和消费贷款在前两个月表现良好 预计平均贷款环比增长1% NII预计环比增长1-2% [4] - Zacks共识预计NII为35.5亿美元 环比增长2% 模型预测贷款增长1.4% [5] 非利息收入 - 抵押贷款利率维持在6%中高位区间 导致再融资和贷款发放量增长有限 预计抵押贷款收入下降 [6] - 住宅和商业抵押贷款收入共识预期为1.304亿美元 环比下降2.7% 模型预测为1.365亿美元 [7] - 市场波动和特朗普关税政策不确定性影响资产管理收入 共识预期为3.878亿美元 模型预测为3.734亿美元 [8] - 全球并购活动好于预期 资本市场和咨询收入共识预期为3.044亿美元 模型预测为3.25亿美元 [10] - 卡和现金管理收入共识预期为7.264亿美元 环比增长4.9% 模型预测为6.94亿美元 [12] 费用与资产质量 - 公司持续投资于业务扩张和数字化 可能导致费用上升 但成本控制措施部分抵消了增长 [13] - 管理层预计调整后非利息支出与第一季度持平 模型预测为34.3亿美元 [14] - 信贷损失拨备预计为2.525亿美元 环比增长15.3% 净核销预计从2.05亿美元增至3亿美元 [15] - 不良资产(NPAs)共识预期为23.8亿美元 环比增长2.2% 不良贷款(NPLs)共识预期为23.3亿美元 增长1.8% [16] 盈利预测 - Zacks共识预计第二季度每股收益3.56美元 同比增长7.9% 收入56.2亿美元 同比增长3.8% [18] - 公司预计总收入环比增长1-3% [18] - 模型预测PNC将再次实现盈利超预期 因其具备+0.18%的盈利ESP和Zacks Rank 3评级 [17] 其他银行股推荐 - Northern Trust Corporation(NTRS)盈利ESP为+0.49% Zacks Rank 1 预计季度每股收益2.06美元 [19][20] - Prosperity Bancshares(PB)盈利ESP为+1.33% Zacks Rank 3 预计季度每股收益1.40美元 [20][21]
Smart Money Going in Senior Health: Key Stocks in Elderly Care
ZACKS· 2025-07-11 22:50
全球人口老龄化趋势 - 全球60岁以上人口数量在2020年首次超过5岁以下儿童 到2050年将从2019年的10亿增至20亿 其中80%以上集中在低收入和中等收入国家 [2] - 美国65岁以上人口到2050年将翻倍 85岁以上人口到2060年将增长两倍 [2] 老年医疗市场增长 - 全球老年护理服务市场规模2022年为1万亿美元 预计到2033年将翻倍 主要驱动力来自制药、医疗设备、长期护理及数字健康解决方案 [3] - 美国老年医疗支出2022年超过1万亿美元 2040年前可能翻倍 [7] 老年健康挑战加剧 - 2010-2024年美国85岁以上老年人死亡率年增4.5% 阿尔茨海默症相关死亡增加40% 心血管疾病仍是首要死因 [4] - 医院使用率显著上升 入院率增加25% 平均住院时间延长 再入院率上升20% 急诊访问量激增40% [4] 制药公司应对策略 - 罗氏推出Elecsys淀粉样蛋白血浆检测组 灵敏度达91% 阴性预测值96.2% 获FDA突破性设备认定 计划未来5年在美国投资500亿美元 [8][9] - 诺和诺德GLP-1类药物Ozempic获FDA批准用于减缓2型糖尿病合并慢性肾病进展 Wegovy高剂量版本在EMA提交申请 临床显示三分之一使用者减重超25% [10][11] 医疗设备创新 - 爱德华生命科学SAPIEN 3 Ultra RESILIA瓣膜获FDA批准用于无症状严重主动脉瓣狭窄 2025年Q1经导管主动脉瓣置换术(TAVR)销售额达10.5亿美元 [12][13] - 史赛克通过收购NICO公司和Vertos Medical增强在微创神经外科和腰椎管狭窄治疗领域的能力 [14][15] 数字健康转型 - 数字健康解决方案如美敦力智能胰岛素笔和雅培Lingo可穿戴设备正在改变老年护理模式 [6] - 远程监测和AI诊断技术推动医院外护理模式发展 但到2030年预计长期护理人员缺口达230万 [6]
Why Barrick Mining (B) is a Top Momentum Stock for the Long-Term
ZACKS· 2025-07-11 22:50
Taking full advantage of the stock market and investing with confidence are common goals for new and old investors, and Zacks Premium offers many different ways to do both.Featuring daily updates of the Zacks Rank and Zacks Industry Rank, full access to the Zacks #1 Rank List, Equity Research reports, and Premium stock screens, the research service can help you become a smarter, more self-assured investor.It also includes access to the Zacks Style Scores. What are the Zacks Style Scores? Developed alongside ...